Cryosurgery is more effective in the treatment of primary, non-superficial basal cell carcinomas when applied during and not prior to a five week imiquimod course: A randomized, prospective, open-label study

European Journal of Dermatology

Volumn 21, Issue 6, 2011, Pages 952-958

  Gaitanis, Georgios ^a   Alexopoulos, Evangelos C ^a   Bassukas, Ioannis D ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Basal cell carcinoma; Clinical trial; Cryosurgery; Imiquimod; Immunocryosurgery

Indexed keywords

IMIQUIMOD;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER RELAPSE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; CONTROLLED STUDY; CRYOSURGERY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; IMMUNOCRYOSURGERY; MALE; MULTIPLE CYCLE TREATMENT; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE;

ADULT; AGED; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; CARCINOMA, BASAL CELL; COMBINED MODALITY THERAPY; CRYOSURGERY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 84856005076     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2011.1524     Document Type: Article

References (34)

1. Rogers HW, Weinstock MA, Harris AR, et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 2010; 146: 283-7.
2. Mudigonda T, Pearce DJ, Yentzer BA, et al. The economic impact of non-melanoma skin cancer: a review. J Natl Compr Canc Netw 2010; 8: 888-96.
3. Gaitanis G, Nomikos K, Vava E, et al. Immunocryosurgery for basal cell carcinoma: results of a pilot, prospective, open-label study of cryosurgery during continued imiquimod application. J Eur Acad Dermatol Venereol 2009; 23: 1427-31.
4. Bassukas ID, Gamvroulia C, Zioga A, et al. Cryosurgery during topical imiquimod: a successful combination modality for lentigo maligna. Int J Dermatol 2008; 47: 519-21.
5. Bassukas ID, Gaitanis G. Combination of cryosurgery and topical imiquimod: does timing matter for successful immunocryosurgery? Cryobiology 2009; 59: 116-7.
6. Bath-Hextall FJ, Perkins W, Bong J, Williams HC. Interventions for basal cell carcinoma of the skin. Cochrane Database Syst Rev 2008; 1: 1-47.
7. Gaitanis G, Nomikos K, Vlachos C, Bassukas ID. Immunocryosurgery for patients with therapeutically challenging basal cell carcinomas: Report of two representative cases. J Dermatol Treat 2010 [Epub ahead of print].
8. Gaitanis G, Kalogeropoulos C, Bassukas ID. Imiquimod can be combined with cryosurgery (immunocryosurgery) for locally advanced periocular basal cell carcinomas. Br J Ophthalmol. 2011; 95: 890-2.
9. Sabel MS. Cryo-immunology: a review of the literature and proposed mechanisms for stimulatory versus suppressive immune responses. Cryobiology 2009; 58: 1-11.
10. Goel R, Anderson K, Slaton J, et al. Adjuvant approaches to enhance cryosurgery. J Biomech Eng 2009; 131: 074003.
11. Jiang J, Bischof J. Effect of timing, dose and interstitial versus nanoparticle delivery of tumor necrosis factor alpha in combinatorial adjuvant cryosurgery treatment of ELT-3 uterine fibroid tumor. Cryo Letters 2010; 31: 50-62.
12. Crowson AN. Basal cell carcinoma: biology, morphology and clinical implications. Mod Pathol 2006; 19: S127-47.
13. Kokoszka A, Scheinfeld N. Evidence-based review of the use of cryosurgery in treatment of basal cell carcinoma. Dermatol Surg 2003; 29: 566-71.
14. Love WE, Bernhard JD, Bordeaux JS. Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review. Arch Dermatol 2009; 145: 1431-8.
15. Vidal D, Matías-Guiu X, Alomar A. Fifty-five basal cell carcinomas treated with topical imiquimod: outcome at 5-year follow-up. Arch Dermatol 2007; 143: 266-8.
16. Shumack S, Robinson J, Kossard S, et al. Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma Comparison of dosing regimens. Arch Dermatol 2002; 138: 1165-71.
17. Gage A, Baust JM, Baust JG. Experimental cryosurgery investigations in vivo. Cryobiology 2009; 59: 229-43.
18. Ismail M, Morgan R, Harrington K, et al. Enhancing prostate cancer cryotherapy using tumour necrosis factor related apoptosisinducing ligand (TRAIL) sensitisation in an in vitro cryotherapy model. Cryobiology 2009; 59: 207-13.
19. Chao BH, He X, Bischof JC. Pre-treatment inflammation induced by TNF-alpha augments cryosurgical injury on human prostate cancer. Cryobiology 2004; 49: 10-27.
20. Schön MP, Schön M, TLR M. TLR8 as targets in cancer therapy. Oncogene 2008; 27: 190-9.
21. Jiang J, Goel R, Schmechel S, et al. Pre-conditioning cryosurgery: Cellular and molecular mechanisms and dynamics of TNF-_ enhanced cryotherapy in an in vivo prostate cancer model system. Cryobiology 2010; 61: 280-8.
22. Osada S, Imai H, Tomita H, et al. Serum cytokine levels in response to hepatic cryoablation. J Surg Oncol 2007; 95: 491-8.
23. Li LY, Yang M, Gao X, et al. Prospective comparison of five mediators of the systemic response after high-intensity focused ultrasound and targeted cryoablation for localized prostate cancer. BJU Int 2009; 104: 1063-7.
24. Chapman WC, Debelak JP, Wright Pinson C, et al. Hepatic cryoablation, but not radiofrequency ablation, results in lung inflammation. Ann Surg 2000; 231: 752-61.
25. Seifert JK, France MP, Zhao J, et al. Large volume hepatic freezing: association with significant release of the cytokines interleukin-6 and tumor necrosis factor a in a rat model. World J Surg 2002; 26: 1333-41.
26. Choileain N, Redmond HP. Cell response to surgery. Arch Surg 2006; 141: 1132-40.
27. Jansen MC, van Hillegersberg R, Schoots IG, et al. Cryoablation induces greater inflammatory and coagulative responses than radiofrequency ablation or laser induced thermotherapy in a rat liver model. Surgery 2010; 147: 686-95.
28. Udagawa M, Kudo-Saito C, Hasegawa G, et al. Enhancement of immunologic tumor regression by intratumoral administration of dendritic cells in combination with cryoablative tumor pretreatment and Bacillus Calmette-Guerin cell wall skeleton stimulation. Clin Cancer Res 2006; 12: 7465-75.
29. Sabel MS, Nehs MA, Su G, et al. Immunologic response to cryoablation of breast cancer. Breast Cancer Res Treat 2005; 90: 97-104.
30. den Brok MH, Sutmuller RP, Nierkens S, et al. Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity. Br J Cancer 2006; 95: 896-905.
31. Si T, Guo Z, Hao X. Immunologic response to primary cryoablation of high-risk prostate cancer. Cryobiology 2008; 57: 66-71.
32. Matin SF, Sharma P, Gill IS, et al. Immunological response to renal cryoablation in an in vivo orthotopic renal cell carcinoma murine model. J Urol 2010; 183: 333-8.
33. Rogers HW, Coldiron BM. A relative value unit-based cost comparison of treatment modalities for nonmelanoma skin cancer: effect of the loss of the Mohs multiple surgery reduction exemption. J Am Acad Dermatol 2009; 61: 96-103.
34. Ozolins M, Williams HC, Armstrong SJ, Bath-Hextall FJ. The SINS trial: a randomized controlled trial of excisional surgery versus imiquimod 5% cream for nodular and superficial basal cell carcinoma. Trials 2010 Apr 21; 11: 42.